NTSPP "4th Thursday" Virtual CME Program--via Zoom

All Psychiatrists and Psychiatrists-in-Training are warmly invited to  

Thursday, April 22, 2021

"Interventional Treatments in Psychiatry"

Alexander Cole, M.D.
Zale-Lipshy Pavilion - Clements University Hospital
Assistant Professor,  UT Southwestern Medical Center

Description:   

Interventional treatments in psychiatry - including repetitive transcranial magnetic stimulation, ketamine-based treatments, and, in particular, electroconvulsive therapy - are among the most effective treatments utilized in psychiatric practice, particularly in depressive symptomatology. However, these treatments are thought to be underutilized in the care of psychiatric patients; factors thought to contribute to this gap include lack of access, cost, administrative barriers (e.g., payer-based coverage criteria), and stigma. In this lecture, we will review the indications for clinically-available interventional treatments with a focus on the risks, benefits, outcomes, and administration of the treatments themselves. Experimental treatments - including magnetic seizure therapy and off-label indications for interventional treatments - will also be briefly reviewed.

Objectives:

1) Describe the indications for and the neurobiological underpinnings of psychiatric disease that form the target of interventional treatments including repetitive transcranial magnetic stimulation (rTMS), ketamine-based treatment, and electroconvulsive therapy,  in psychiatric practice

2) Describe how interventional treatments are administered and describe the risks, benefits, and outcomes of each treatment for specific psychiatric indications. Utilize this understanding in order to better inform the clinical care of patients, including appropriate referrals for treatment-resistant depression treatment.

References: 

1) Voineskos, D., Daskalakis, Z.J., & Blumberger, D.M. (2020). Management of Treatment-Resistant Depression: Challenges and Strategies. Neuropsychiatric Disease and Treatment, 16, 221-234. https://dx.doi.org/10.2147%2FNDT.S198774

2) Lefaucheur, J-P. et al (2014). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology, 125, 2150-2206. https://doi.org/10.1016/j.clinph.2014.05.021

3) Molero, P. et al (2018). Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review. CNS Drugs, 32, 411-420.

Continuing Education Accreditation:

Physicians: this activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Psychoanalytic Association and the Dallas Psychoanalytic Center. The American Psychoanalytic Association is accredited by the ACCME to provide continuing medical education for physicians.

The American Psychoanalytic Association designates this Live Activity for a maximum of_1.5__AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologists: pursuant to the Texas State Board of Examiners of Psychologists rule 461.11(c)(2)(B) the Dallas Psychoanalytic Center qualifies as an approved CEU provider. Psychologists can claim credit commensurate with the extent of their participation in the activity.

Social Workers: the Dallas Psychoanalytic Center is approved by the Texas State Board of Social Work Examiners (Provider #6949) to provide continuing education activities for social workers.

Licensed Professional Counselors: pursuant to Texas Administrative Code related to the Texas State Board Of Examiners Of Professional Counselors Rule 681.142 the Dallas Psychoanalytic Center qualifies to provide continuing education for licensed professional counselors in Texas.

IMPORTANT DISCLOSURE INFORMATION FOR ALL LEARNERS: None of the planners and presenters of this

CME program have any relevant financial relationships to disclose.

1.5 AMA PRA Category 1 CME Credit Available. 

Agenda:
6:30 pm        NTSPP Zoom Meeting Room Opens. Get settled in and socialize a bit
7:00 pm        Meeting Begins. Announcements and Introductions. Speaker Program Begins by 7:15pm
8:15 pm        Q & A  Period
8:30 pm        Meeting Adjourns

REGISTER NOW!